These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 347199)

  • 21. Serum prolactin and antipsychotic responses to pimozide in schizophrenia.
    Siris SG; van Kammen DP; De Fraites EG
    Psychopharmacol Bull; 1978 Jan; 14(1):11-4. PubMed ID: 625528
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum prolactin as an index of dopamine receptor blockade in acute schizophrenia [proceedings].
    Cotes PM; Crow TJ; Johnstone EC
    Br J Clin Pharmacol; 1977 Oct; 4(5):651P. PubMed ID: 911637
    [No Abstract]   [Full Text] [Related]  

  • 24. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral effects of central catecholamines: concluding remarks.
    Vogt M
    J Psychiatr Res; 1974; 11():183-4. PubMed ID: 4461789
    [No Abstract]   [Full Text] [Related]  

  • 27. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
    Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum prolactin levels in unmedicated schizophrenic patients.
    Meltzer HY; Sachar EJ; Frantz AG
    Arch Gen Psychiatry; 1974 Oct; 31(4):564-9. PubMed ID: 4422004
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dopamine blockade on gonadotropins and testosterone in men.
    Siris SG; Siris ES; van Kammen DP; Docherty JP; Alexander PE; Bunney WE
    Am J Psychiatry; 1980 Feb; 137(2):211-4. PubMed ID: 7352577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of 2 Hydroxyestradiol to interact with dopamine inhibition of human prolactin secretion in vitro and with dopamine receptors of prolactin-secreting adenomas.
    Peillon F; Brandi AM; Bression D; Le Dafniet M; Racadot J
    Biochem Biophys Res Commun; 1983 Apr; 112(1):42-6. PubMed ID: 6838618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin and neuroleptics: clinical implications for efficacy and toxicity. The effect of neuroleptics and alpha-methyl-para-tyrosine on serum prolactin levels in laboratory animals and man.
    Meltzer HY; Fang VS; Goode DJ
    Psychopharmacol Bull; 1978 Jan; 14(1):5-7. PubMed ID: 625539
    [No Abstract]   [Full Text] [Related]  

  • 36. Dopamine and schizophrenia.
    Westerink BH; Korf J
    Lancet; 1976 Oct; 2(7988):749. PubMed ID: 61434
    [No Abstract]   [Full Text] [Related]  

  • 37. Clozapine: plasma levels and prolactin response.
    Kane JM; Cooper TB; Sachar EJ; Halpern FS; Bailine S
    Psychopharmacology (Berl); 1981; 73(2):184-7. PubMed ID: 6785813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight change during various neuropharmacologic manipulations in psychotic inpatients.
    Carman JS; Wyatt RJ; Nasrallah HA; O'Brien P; Gillin JC
    Acta Cient Venez; 1978; 29(3):178-80. PubMed ID: 757726
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine and schizophrenia--proof at last?
    Harrison PJ
    Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of adrenalectomy and dexamethasone treatment on prolactin secretion of lactating rats.
    Horváth KM; Bánky Z; Tóth BE; Halász B; Nagy GM
    Brain Res Bull; 2001 Dec; 56(6):589-92. PubMed ID: 11786246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.